GLP1R and type 2 diabetes mellitus: In this Review, our focus is on the precision deployment of glucagon-like peptide-1 receptor agonists (GLP-1RAs), with a particular emphasis on clinical and genetic features that differentially alter the response to GLP-1RAs compared with other classes of T2D drugs.